USFDA issues warning letter to Indoco Remedies’ Goa plantPost published:April 12, 2017Post category:Industry NewsUSFDA inspectors found significant violations of manufacturing practice regulations for finished pharmaceuticals at Indoco Remedies after inspecting it last year Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostCarlsberg India launches new beer Tuborg Classic Next PostApple’s Make in India tax demands rejected due to GST, says minister You Might Also Like ABB announces business model change for EPC divisions December 21, 2017 HARTING announces innauguration of European Distribution Center July 3, 2019 Portescap announces 30ECT slotless DC motor May 9, 2018